Additionally, KRAS mutant NCI-H1792 and NCI-H23 lung cancer cells also showed upregulated ciliogenesis and increased Hedgehog pathway activation (Figures S5A–S5I and S5K; Table 1) in response to MEK inhibition. This evidence concerns the gene KRAS and lung cancer.